Risk of glomerular diseases, proteinuria and hematuria following mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines

• Published in: Nephrology, dialysis, transplantation Vol. 38; no. 1; pp. 129 - 137
• Main Authors: Cheng, Franco Wing Tak, Wong, Carlos King Ho, Qin, Simon Xiwen, Chui, Celine Sze Ling, Lai, Francisco Tsz Tsun, Li, Xue, Wan, Eric Yuk Fai, Chan, Esther W, Au, Chi Ho, Ye, Xuxiao, Tang, Sydney Chi Wai, Wong, Ian Chi Kei
• Format: Journal Article
• Language: English
• Published: England Oxford University Press 23.01.2023
• Subjects: BNT162 Vaccine; COVID-19; COVID-19 Vaccines; Hematuria; Humans; Kidney Diseases; Proteinuria; RNA, Messenger; SARS-CoV-2; COVID-19; hematuria, proteinuria; glomerular diseases

ABSTRACT Background With accruing case reports on de novo or relapsing glomerular diseases (GD) following different severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines, we evaluated the risk of GD following BNT162b2 and CoronaVac vaccines. Methods A modified self-controlled case se...